Castle Biosciences, Inc. (CSTL) Q2 2021 Earnings Results

Castle Biosciences Misses on EPS, Stock Up 0.04%

Castle Biosciences reported a loss per share that was worse than expected, but the stock saw a slight increase of 0.04% in reaction. This could indicate that investors are not overly concerned about the earnings miss, possibly due to other factors not disclosed in the earnings call. Without guidance or additional commentary, it's difficult to assess the company's outlook.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.35	N/A	-20.69%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

Castle Biosciences Misses on EPS, Stock Up 0.04%

Key numbers

Management commentary

Castle Biosciences, Inc.

More earnings this week

Castle Biosciences Misses on EPS, Stock Up 0.04%

Key numbers

Management commentary